Sandbox:Preeti: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 47: | Line 47: | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! align="center" style="background:#4479BA; color: #FFFFFF;" + | | ||
! colspan="2" |Hodgkin's Lymphoma | ! colspan="2" align="center" style="background:#DCDCDC;" + |Hodgkin's Lymphoma | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 79: | Line 79: | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |B Cell Lymphoma | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |B Cell Lymphoma | ||
! colspan="2" |Precursor B-cell lymphoblastic leukemia/lymphoma | ! colspan="2" align="center" style="background:#DCDCDC;" + |Precursor B-cell lymphoblastic leukemia/lymphoma | ||
| | | | ||
* Precursor B-cell Lymphoma | * Precursor B-cell Lymphoma | ||
Line 111: | Line 111: | ||
|- | |- | ||
! | ! | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |[[Follicular lymphoma]] | |||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
* Reciprocal translocation t(14;18)(q32;q21) | * Reciprocal translocation t(14;18)(q32;q21) | ||
| | | | ||
Line 136: | Line 135: | ||
| | | | ||
* [[Seizures]] | * [[Seizures]] | ||
*[[Chest pain]] | *[[Chest pain]] | ||
*[[Bone pain]] | *[[Bone pain]] | ||
Line 155: | Line 153: | ||
|- | |- | ||
! | ! | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Mantle cell lymphoma | |||
| | | | ||
* [[CD5 (protein)|CD5]] positive antigen in pregerminal center of B-cell | * [[CD5 (protein)|CD5]] positive antigen in pregerminal center of B-cell | ||
Line 213: | Line 211: | ||
|- | |- | ||
! | ! | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Diffuse large B cell lymphoma | |||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
Line 247: | Line 245: | ||
| | | | ||
| | | | ||
'''Centroblastic''' | |||
*Medium-to-large-sized [[Lymphocyte|lymphocytes]] | *Medium-to-large-sized [[Lymphocyte|lymphocytes]] | ||
*Monomorphic | *Monomorphic | ||
'''Immunoblastic''' | |||
*> 90% immunoblasts | *> 90% immunoblasts | ||
*Trapezoid shaped large lymphoid cells with significant [[basophilic]] cytoplasm | *Trapezoid shaped large lymphoid cells with significant [[basophilic]] cytoplasm | ||
'''Anaplastic''' | |||
*Very large cells with a round, oval, or polygonal shape that may resemble Reed-Sternberg cells | *Very large cells with a round, oval, or polygonal shape that may resemble Reed-Sternberg cells | ||
| | | | ||
Line 292: | Line 290: | ||
|- | |- | ||
! | ! | ||
! colspan="2" |[[Burkitt lymphoma]] | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Burkitt lymphoma]] | ||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
Line 314: | Line 312: | ||
* [[Proptosis]] | * [[Proptosis]] | ||
* Jaw mass | * Jaw mass | ||
* [[Abdominal mass|Abdominal masses]] | * [[Abdominal mass|Abdominal masses]] | ||
* [[Ascites]] | * [[Ascites]] | ||
* [[Lymphadenopathy|Peripheral lymphadenopathy]] | * [[Lymphadenopathy|Peripheral lymphadenopathy]] | ||
| | | | ||
Line 353: | Line 349: | ||
|- | |- | ||
! | ! | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |B cell chronic lymphocytic leukemia/small lymphocytic lymphoma | |||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
Line 384: | Line 380: | ||
|- | |- | ||
! | ! | ||
! rowspan="3" align="center" style="background:#DCDCDC;" + |Marginal zone lymphoma | |||
|Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type | ! align="center" style="background:#DCDCDC;" + |Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type | ||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
Line 416: | Line 412: | ||
|- | |- | ||
| | | | ||
|[[Splenic marginal zone lymphoma]] | ! align="center" style="background:#DCDCDC;" + |[[Splenic marginal zone lymphoma]] | ||
| | | | ||
* Clonal rearrangements of the [[immunoglobulin]] genes (heavy and light chains) | * Clonal rearrangements of the [[immunoglobulin]] genes (heavy and light chains) | ||
** Deletion 7q21-32 | ** Deletion 7q21-32 | ||
** Translocations of the CDK6 gene located at 7q21. | ** Translocations of the CDK6 gene located at 7q21. | ||
Line 445: | Line 441: | ||
* [[CD79a]] | * [[CD79a]] | ||
| | | | ||
* [[B-cells]] replace the normal [[white pulp]] of the [[spleen]] | * [[B-cells]] replace the normal [[white pulp]] of the [[spleen]] | ||
* The neoplastic cells compromise | * The neoplastic cells compromise | ||
** Small [[lymphocytes]] | ** Small [[lymphocytes]] | ||
Line 462: | Line 458: | ||
|- | |- | ||
| | | | ||
|[[Nodal marginal zone B-cell lymphoma]] | ! align="center" style="background:#DCDCDC;" + |[[Nodal marginal zone B-cell lymphoma]] | ||
| | | | ||
* Arise from memory B cells. Include | * Arise from memory B cells. Include | ||
Line 510: | Line 506: | ||
|- | |- | ||
| | | | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) | |||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
Line 541: | Line 537: | ||
|- | |- | ||
| | | | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |[[Hairy cell leukemia]] | |||
| | | | ||
* Production of [[Cytokine|cytokines]], such as [[TNF alpha]] and IL-2R, provide important stimuli for [[malignant]] [[B cell|B cells]] proliferation in hairy cell leukemia. | * Production of [[Cytokine|cytokines]], such as [[TNF alpha]] and IL-2R, provide important stimuli for [[malignant]] [[B cell|B cells]] proliferation in hairy cell leukemia. | ||
Line 603: | Line 599: | ||
|- | |- | ||
| | | | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Precursor T-cell lymphoblastic leukemia/lymphoma | |||
| | | | ||
* '''Precursor T-cell Lymphomas''' | * '''Precursor T-cell Lymphomas''' | ||
Line 635: | Line 631: | ||
|- | |- | ||
| | | | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Adult T cell leukemia/lymphoma | |||
| | | | ||
| | | | ||
Line 665: | Line 661: | ||
|- | |- | ||
|T cell lymphoma | |T cell lymphoma | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Anaplastic large cell lymphoma | |||
| | | | ||
| | | | ||
Line 695: | Line 691: | ||
|- | |- | ||
| | | | ||
|Cutaneous T-cell lymphoma | ! align="center" style="background:#DCDCDC;" + |Cutaneous T-cell lymphoma | ||
|[[Mycosis fungoides]] / [[Sézary syndrome]] | ! align="center" style="background:#DCDCDC;" + |[[Mycosis fungoides]] / [[Sézary syndrome]] | ||
| | | | ||
* The [[tumor]] [[Cell (biology)|cells]] originate from [[memory T cells]] or [[skin]] homing [[CD4+ T cells]] expressing [[cutaneous]] [[lymphocyte]] [[antigen]] (CLA) and [[chemokine]] [[receptors]] [[CCR4]]<nowiki/>and CCR7. | * The [[tumor]] [[Cell (biology)|cells]] originate from [[memory T cells]] or [[skin]] homing [[CD4+ T cells]] expressing [[cutaneous]] [[lymphocyte]] [[antigen]] (CLA) and [[chemokine]] [[receptors]] [[CCR4]]<nowiki/>and CCR7. | ||
Line 706: | Line 702: | ||
| | | | ||
* [[Epidermis (skin)|Epidermal]] [[atrophy]] or poikiloderma | * [[Epidermis (skin)|Epidermal]] [[atrophy]] or poikiloderma | ||
* Generalized [[itching]]([[pruritus]]) | * Generalized [[itching]]([[pruritus]]) | ||
* [[Pain]] in the affected area of the skin. | * [[Pain]] in the affected area of the skin. | ||
Line 721: | Line 716: | ||
| | | | ||
| | | | ||
* Cutaneous | * Cutaneous manifestations | ||
| | | | ||
| | | | ||
Line 740: | Line 735: | ||
|- | |- | ||
| | | | ||
! rowspan="6" align="center" style="background:#DCDCDC;" + |Peripheral T-cell lymphoma | |||
|Subcutaneous panniculitis-like T-cell lymphoma | ! align="center" style="background:#DCDCDC;" + |Subcutaneous panniculitis-like T-cell lymphoma | ||
| | | | ||
| | | | ||
Line 771: | Line 766: | ||
|- | |- | ||
| | | | ||
|Hepatosplenic gamma-delta T-cell lymphoma | ! align="center" style="background:#DCDCDC;" + |Hepatosplenic gamma-delta T-cell lymphoma | ||
| | | | ||
| | | | ||
Line 801: | Line 796: | ||
|- | |- | ||
| | | | ||
|Enteropathy-type intestinal T-cell lymphoma | ! align="center" style="background:#DCDCDC;" + |Enteropathy-type intestinal T-cell lymphoma | ||
| | | | ||
| | | | ||
Line 831: | Line 826: | ||
|- | |- | ||
| | | | ||
|Extranodal T-cell lymphoma, nasal type | ! align="center" style="background:#DCDCDC;" + |Extranodal T-cell lymphoma, nasal type | ||
| | | | ||
| | | | ||
Line 861: | Line 856: | ||
|- | |- | ||
| | | | ||
|Angioimmunoblastic T-cell lymphoma | ! align="center" style="background:#DCDCDC;" + |Angioimmunoblastic T-cell lymphoma | ||
| | | | ||
| | | | ||
Line 891: | Line 886: | ||
|- | |- | ||
| | | | ||
|Peripheral T-cell lymphoma, unspecified | ! align="center" style="background:#DCDCDC;" + |Peripheral T-cell lymphoma, unspecified | ||
| | | | ||
| | | |
Revision as of 18:56, 31 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Category | Disease | Etiology | Mechanism | Clinical manifestations | Paraclinical findings | Gold standard | Associated findings | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lab findings | Imaging | ||||||||||||||||||||||||||||
Demography | History | Symptoms | Signs | CBC | PBS | LFT | PT/PTT | Immunochemistry | Histopathology | Other | |||||||||||||||||||
Inherited | Acquired | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | |||||||||||||||
HL | |||||||||||||||||||||||||||||
Hodgkin's Lymphoma | |||||||||||||||||||||||||||||
NHL | |||||||||||||||||||||||||||||
B Cell Lymphoma | Precursor B-cell lymphoblastic leukemia/lymphoma |
|
|||||||||||||||||||||||||||
Follicular lymphoma |
|
+ | + |
|
|
+ | |||||||||||||||||||||||
Mantle cell lymphoma |
|
|
|
CBC
|
|
|
|||||||||||||||||||||||
Diffuse large B cell lymphoma |
|
|
|
↓ | ↓ | Nl to ↓ |
|
Centroblastic
Immunoblastic
Anaplastic
|
|
||||||||||||||||||||
Category | Disease | Etiology | Inherited | Acquired | Demography | History | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | PBS | LFT | PT/PTT | Immunochemistry | Histopathology | Other lab findings | Imaging | Gold standard | Associated findings | |
Burkitt lymphoma |
|
|
|
|
|||||||||||||||||||||||||
B cell chronic lymphocytic leukemia/small lymphocytic lymphoma |
|
||||||||||||||||||||||||||||
Marginal zone lymphoma | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type |
|
|||||||||||||||||||||||||||
Splenic marginal zone lymphoma |
|
|
|||||||||||||||||||||||||||
Nodal marginal zone B-cell lymphoma |
|
|
|
|
|||||||||||||||||||||||||
Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) |
|
||||||||||||||||||||||||||||
Hairy cell leukemia |
|
|
|
||||||||||||||||||||||||||
Precursor T-cell lymphoblastic leukemia/lymphoma |
|
||||||||||||||||||||||||||||
Adult T cell leukemia/lymphoma | |||||||||||||||||||||||||||||
T cell lymphoma | Anaplastic large cell lymphoma | ||||||||||||||||||||||||||||
Cutaneous T-cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
|||||||||||||||||||||||||
Peripheral T-cell lymphoma | Subcutaneous panniculitis-like T-cell lymphoma | ||||||||||||||||||||||||||||
Hepatosplenic gamma-delta T-cell lymphoma | |||||||||||||||||||||||||||||
Enteropathy-type intestinal T-cell lymphoma | |||||||||||||||||||||||||||||
Extranodal T-cell lymphoma, nasal type | |||||||||||||||||||||||||||||
Angioimmunoblastic T-cell lymphoma | |||||||||||||||||||||||||||||
Peripheral T-cell lymphoma, unspecified |